News

Researchers prevent self-perforation of cells with chemical that prevents membrane-destroying protein from aggregating.

Combining a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.

Scientists have identified enzymes — from the human gut — that can efficiently turn type A and B blood into the universally usable O.

Gene therapy with telomerase was developed in 2012 and has proved effective in mice against infarction, as well as in mouse models of aplastic anaemia and idiopathic pulmonary fibrosis associated to short telomeres.

Two molecules, Sprouty 1 and Sprouty 2, modify the survival of effector T cells and the development of memory CD8 T cells. These findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

Researchers hope their neuronal stem cell scaffold could be surgically implanted to help spinal cord injury patients.

New microfluidics-based chip allows for the manipulation and nucleic-acid analysis of individual cells.

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

The never-ending fight against bacteria has taken a turn in humanity’s favor with the announcement of a tool that could give the upper hand in drug research.